Severity and pattern of bone mineral loss in endocrine causes of osteoporosis as compared to age-related bone mineral loss

• Published in: Journal of postgraduate medicine Vol. 62; no. 3; pp. 162 - 169
• Main Authors: Dutta, D, Dharmshaktu, P, Aggarwal, A, Gaurav, K, Bansal, R, Devru, N, Garga, U, Kulshreshtha, B
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer - Medknow Publications 01-07-2016; Medknow Publications and Media Pvt. Ltd; Medknow Publications & Media Pvt. Ltd; Medknow Publications & Media Pvt Ltd
• Subjects: Absorptiometry, Photon; Adult; Age Factors; Aged; Aging; Aging (Biology); Andropause; Bone Density; Complications and side effects; Development and progression; Diabetes Mellitus, Type 2 - epidemiology; Endocrine diseases; Female; Graves Disease - complications; Graves Disease - epidemiology; Health aspects; Humans; India; Male; Middle Aged; Original; Osteoporosis; Osteoporosis - complications; Osteoporosis - epidemiology; Osteoporosis - metabolism; Pelvic Bones - metabolism; Pelvic Bones - physiopathology; Postmenopause; Prevalence; Retrospective Studies; Severity of Illness Index; Vitamin D Deficiency - complications; Vitamin D Deficiency - epidemiology; Bone mineral density (BMD); Graves′ disease (GD); hypopituitarism; hypogonadism; osteoporosis
• ISSN: 0022-3859; 0972-2823
• DOI: 10.4103/0022-3859.183170

Background: Data are scant on bone health in endocrinopathies from India. This study evaluated bone mineral density (BMD) loss in endocrinopathies [Graves′ disease (GD), type 1 diabetes mellitus (T1DM), hypogonadotrophic hypogonadism (HypoH), hypergonadotropic hypogonadism (HyperH), hypopituitarism, primary hyperparathyroidism (PHPT)] as compared to age-related BMD loss [postmenopausal osteoporosis (PMO), andropause]. Materials and Methods: Retrospective audit of records of patients >30 years age attending a bone clinic from August 2014 to January 2016 was done. Results: Five-hundred and seven records were screened, out of which 420 (females:male = 294:126) were analyzed. A significantly higher occurrence of vitamin D deficiency and insufficiency was noted in T1DM (89.09%), HyperH (85%), and HypoH (79.59%) compared to age-related BMD loss (60.02%; P < 0.001). The occurrence of osteoporosis among females and males was 55.41% and 53.97%, respectively, and of osteopenia among females and males was 28.91% and 32.54%, respectively. In females, osteoporosis was significantly higher in T1DM (92%), HyperH (85%), and HypoH (59.26%) compared to PMO (49.34%; P < 0.001). Z score at LS, TF, NOF, and greater trochanter (GT) was consistently lowest in T1DM women. Among men, osteoporosis was significantly higher in T1DM (76.67%) and HypoH (54.55%) compared to andropause (45.45%; P = 0.001). Z score at LS, TF, NOF, GT, and TR was consistently lowest in T1DM men. In GD, the burden of osteoporosis was similar to PMO and andropause. BMD difference among the study groups was not significantly different after adjusting for body mass index (BMI) and vitamin D. Conclusion: Low bone mass is extremely common in endocrinopathies, warranting routine screening and intervention. Concomitant vitamin D deficiency compounds the problem. Calcium and vitamin D supplementations may improve bone health in this setting.